CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials (2025)
Attributed to:
MICA: Targeting the RA synovial fibroblast via cyclin dependent kinase inhibition - a phase IIa study
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.eclinm.2024.102987
Publication URI: http://dx.doi.org/10.1016/j.eclinm.2024.102987
Type: Journal Article/Review
Parent Publication: eClinicalMedicine